snf22 Antibody

What is SNF2H and what role does it play in chromatin remodeling?

SNF2H (also known as SMARCA5) is the catalytic subunit of ATP-dependent chromatin remodeling complexes. It belongs to the SWI/SNF family of proteins that facilitate numerous DNA-mediated processes by altering nucleosome positioning and structure. SNF2H functions as part of the ISWI (Imitation SWI) complexes that regulate chromatin accessibility for transcription factors and other DNA-binding proteins. The protein contains conserved helicase-like ATPase domains that couple ATP hydrolysis to mechanical work of repositioning nucleosomes . Its molecular weight is approximately 125 kDa, and it is widely expressed in human and monkey cells as detected by specific antibodies . SNF2H/SWI2 family proteins are critical for normal cell development, and mutations in these genes have been associated with various cancers, particularly leukemia .

What applications are SNF2H antibodies suitable for in research?

SNF2H antibodies are applicable across multiple experimental techniques essential for chromatin biology research. Based on validated antibody performance data, SNF2H antibodies can be effectively used for Western blotting (typically at 1:1000 dilution), immunoprecipitation (IP), immunohistochemistry on paraffin-embedded tissues (IHC-P), immunocytochemistry/immunofluorescence (ICC/IF), and immunohistochemistry on frozen sections (IHC-FrFl) . These antibodies have been validated with human and mouse samples, with some showing cross-reactivity to monkey proteins due to high sequence homology . The versatility of these antibodies allows researchers to investigate SNF2H localization, protein-protein interactions, and expression levels across different experimental contexts.

How do I select the appropriate SNF2H antibody for my specific research application?

Selection of an appropriate SNF2H antibody should be guided by several critical factors:

• Application compatibility: Different antibodies exhibit varying performance across applications. For instance, some antibodies perform optimally in Western blotting but may have limitations in immunofluorescence studies .

• Species reactivity: Verify that the antibody recognizes your species of interest. While many SNF2H antibodies react with human proteins, cross-reactivity with mouse or other model organisms varies between products .

• Epitope location: Consider the epitope location within the SNF2H protein. Antibodies targeting different regions may yield different results, especially if studying specific domains or if certain regions are masked in protein complexes .

• Validation evidence: Review available validation data, including knockdown/knockout controls, which are crucial for confirming specificity, as demonstrated in NRF2 antibody validation studies that revealed potential cross-reactivity issues .

• Clonality: Monoclonal antibodies often provide higher specificity, while polyclonal antibodies may offer stronger signals but with potential cross-reactivity concerns .

What are the optimal conditions for Western blotting using SNF2H antibodies?

Successful Western blotting using SNF2H antibodies requires attention to several key parameters:

When analyzing Western blot results, be aware that SNF2H migrates at approximately 125 kDa on SDS-PAGE gels . Cross-reactivity with other proteins of similar molecular weight may occur, so proper controls are essential. As demonstrated in research with other nuclear proteins like NRF2, some antibodies may co-detect unrelated proteins that migrate at similar positions in SDS-PAGE, which can lead to misinterpretation of results .

What considerations are important for immunoprecipitation experiments with SNF2H antibodies?

Immunoprecipitation (IP) of SNF2H requires careful optimization to maintain protein complex integrity while achieving specific enrichment:

• Lysis buffer selection: Use buffers that maintain native protein conformation while effectively solubilizing nuclear proteins. RIPA buffers may be too harsh for preserving protein-protein interactions, whereas NP-40 or Triton X-100 based buffers (0.5-1%) are often more suitable for chromatin-associated proteins .

• Antibody amount: Typically, 3-5 μg of antibody per mg of lysate provides good enrichment without excessive non-specific binding, as demonstrated in published IP protocols .

• Pre-clearing: Pre-clear lysates with protein A/G beads to reduce non-specific binding.

• Controls: Include both negative controls (non-specific IgG) and input controls to accurately assess enrichment efficiency.

• Washing stringency: Balance between removing non-specific interactions and preserving specific interactions. Typically, 3-5 washes with decreasing salt concentrations work well.

• Complex analysis: When studying SNF2H as part of larger complexes like SWI/SNF, gentle elution conditions help preserve complex integrity for downstream analysis of associated proteins .

Studies have successfully used IP techniques to isolate and characterize SNF2H-containing complexes, revealing important insights into their composition and function in chromatin remodeling processes .

How can I investigate the ATP-dependent remodeling activity of purified SNF2H/SWI2 complexes?

Investigating the ATP-dependent remodeling activity of SNF2H/SWI2 complexes involves several sophisticated approaches:

• Nucleosome sliding assays: These assays use reconstituted mononucleosomes with fluorescently labeled DNA to measure repositioning activity. The assay involves:

  • Assembly of positioned nucleosomes using purified histones and DNA fragments

  • Incubation with purified SNF2H/SWI2 complexes in the presence of ATP

  • Analysis of nucleosome positions using native PAGE or FRET-based approaches

• ATPase activity assays: Measure ATP hydrolysis rates using:

  • Malachite green assay for phosphate release

  • Coupled enzyme assays (NADH absorbance)

  • Radiometric assays with [γ-32P]ATP

• Restriction enzyme accessibility assays: These assess chromatin remodeling by measuring the exposure of restriction sites within nucleosomal DNA after remodeling.

• Structure-function analysis: Comparing wild-type and mutant complexes can reveal the roles of specific domains. For example, studies of motif V in the Swi2/Snf2 ATPase domain identified residues specifically required for coupling ATP hydrolysis to chromatin-remodeling activity, without affecting ATP binding or complex assembly .

To control for potential artifacts, experiments should include:

• ATP-depleted controls

• ATPase-dead mutants (e.g., mutations in Walker A/B motifs)

• DNA-only controls to distinguish nucleosome-specific activities

What are the critical considerations when analyzing SNF2H localization by immunofluorescence?

Successful immunofluorescence studies of SNF2H localization require careful attention to several methodological aspects:

• Fixation method: Paraformaldehyde (4%) fixation for 10 minutes typically preserves nuclear architecture while maintaining epitope accessibility. Methanol fixation may be preferable for certain antibodies .

• Permeabilization: Use 0.1-0.3% Triton X-100 to ensure antibody access to nuclear proteins while maintaining nuclear morphology.

• Blocking: Incubate with 1-5% BSA combined with normal serum (from the species of the secondary antibody) to reduce non-specific binding .

• Antibody validation: Critical controls should include:

  • Peptide competition assays

  • siRNA knockdown samples

  • Known expression patterns in different cell types

• Co-localization studies: Combine SNF2H staining with markers for:

  • Nuclear compartments (e.g., PML bodies, nucleoli)

  • Chromatin states (e.g., H3K9me3 for heterochromatin)

  • DNA damage sites (e.g., γH2AX)

• Image acquisition: Use confocal microscopy with appropriate controls for:

  • Spectral bleed-through

  • Antibody cross-reactivity

  • Background autofluorescence

When interpreting SNF2H immunofluorescence results, remember that antibody specificity in immunofluorescence doesn't always correlate with Western blot specificity. Some antibodies that cross-react with unrelated proteins in Western blots may still specifically recognize nuclear SNF2H in immunofluorescence, though validation with knockdown controls remains essential .

How can I investigate the role of SNF2H in T-cell development and lineage commitment?

Investigating SNF2H's role in T-cell development requires integrated approaches spanning molecular, cellular, and developmental techniques:

• Conditional knockout models: Generate T-cell specific knockout models using Cre-loxP systems (e.g., Lck-Cre or CD4-Cre) to study stage-specific roles of SNF2H in T-cell development .

• Flow cytometry analysis: Assess T-cell populations using markers including:

  • CD4 and CD8 for helper and cytotoxic T-cells

  • CD25 and CD44 for developmental stages

  • Activation markers like CD69 and CD62L

• Chromatin immunoprecipitation (ChIP): Determine SNF2H binding at key regulatory elements:

  • CD4 silencer regions where SNF2H complexes facilitate RUNX1 binding

  • CD8 enhancer elements

  • Developmental stage-specific regulatory elements

• Gene expression analysis: Compare transcriptome changes between wild-type and SNF2H-deficient T-cells at various developmental stages.

• Mechanistic studies: Investigate SNF2H interactions with lineage-determining transcription factors like RUNX1 and how these interactions regulate chromatin accessibility at key target genes .

Previous research has established that SNF2H plays a crucial role in T-cell development by binding to CD4 silencer elements in double-negative T-cells, repressing CD4 receptor expression while promoting CD8 expression. SMARCE1-containing SMARCA4 complexes are specifically required for remodeling chromatin at CD4 silencer regions, enabling binding of the RUNX1 transcription repressor .

How can I differentiate between specific and non-specific signals when using SNF2H antibodies?

Distinguishing between specific and non-specific signals requires systematic validation approaches:

• Genetic validation:

  • siRNA/shRNA knockdown: Reduction in signal intensity proportional to knockdown efficiency indicates specificity

  • CRISPR knockout: Complete loss of signal in knockout cells confirms specificity

  • Overexpression: Increased signal intensity in overexpressing cells supports specificity

• Biochemical validation:

  • Peptide competition: Pre-incubating antibody with immunizing peptide should abolish specific signals

  • Multiple antibodies: Using antibodies against different epitopes should yield consistent results

  • Size verification: SNF2H should migrate at approximately 125 kDa

• Cross-reactivity assessment:

  • Mass spectrometry identification of detected bands can reveal co-migrating proteins

  • Analysis under different conditions (e.g., activation, inhibition) should show expected biological responses

Recent studies with other nuclear proteins have highlighted that some antibodies may detect co-migrating proteins with similar molecular weights. For example, some NRF2 antibodies were found to recognize calmegin, an ER-residing chaperone that co-migrates with NRF2 in SDS-PAGE. This cross-reactivity was only identified through careful mass spectrometry analysis . Similar validation approaches should be applied to SNF2H antibodies to ensure data reliability.

What are the potential pitfalls in interpreting chromatin remodeling assays with mutant SNF2H/SWI2 proteins?

Interpreting chromatin remodeling assays with mutant SNF2H/SWI2 proteins requires consideration of several potential complications:

• Complex assembly effects: Mutations might subtly alter complex composition or stoichiometry without completely disrupting assembly. Careful analysis of purified complexes using SDS-PAGE/silver stain and Western blot is essential to confirm proper assembly before attributing phenotypes to enzymatic activity defects .

• Coupling versus catalytic defects: Some mutations may selectively impair the coupling between ATP hydrolysis and mechanical work without affecting ATP binding or hydrolysis rates. For example, mutations in motif V of the Swi2/Snf2 ATPase domain specifically disrupt the coupling mechanism . Differentiating between these possibilities requires:

  • Measuring ATPase activity independently of remodeling

  • Comparing ATP hydrolysis rates in the presence and absence of nucleosomes

  • Correlating ATP consumption with remodeling outcomes

• Substrate specificity changes: Mutations might alter substrate preferences rather than abolishing activity completely. Testing multiple nucleosome substrates with varied DNA sequences and histone modifications can reveal such specificity shifts.

• Allosteric effects: Some mutations might affect communication between regulatory domains and the catalytic core. Analyzing truncation mutants alongside point mutants can help dissect these regulatory mechanisms.

• Dominant negative effects: When expressing mutant proteins in vivo, distinguishing between loss-of-function and dominant-negative effects requires careful titration experiments and comparison with null mutants .

Studies of the conserved helicase-like ATPase domain in Swi2/Snf2 have demonstrated that different mutations can produce distinct mechanistic defects, highlighting the importance of comprehensive biochemical characterization .

How are SNF2H/SWI2 proteins implicated in cancer and leukemia?

SNF2H/SWI2 family proteins play critical roles in cancer development and progression through several mechanisms:

• Mutational landscape: Analysis of large-scale data from the International Cancer Genome Consortium (ICGC) has revealed frequent mutations in genes encoding SNF2 helicase-like enzymes and auxiliary chromatin remodeling complex (CRC) subunits in leukemia . These mutations can lead to:

  • Altered chromatin accessibility at key oncogenes and tumor suppressors

  • Dysregulated developmental programs in hematopoietic cells

  • Impaired DNA damage response pathways

• Experimental evidence: Functional studies have demonstrated that:

  • Defects in chromatin remodeling caused by mutations or aberrant expression of these proteins may contribute to leukemogenesis

  • The SMARCE1-containing SMARCA4 complex regulates T-cell development through chromatin remodeling at lineage-specific genes

  • SNF2H is involved in DNA damage repair pathways, and its dysfunction can lead to genomic instability

• Clinical relevance: Motif V of the human Swi2p/Snf2p homolog, Brg1p, has been identified as a possible hot spot for mutational alterations associated with cancers . These findings suggest that disruption of the coupling between ATP hydrolysis and chromatin remodeling may be a key mechanism in cancer development.

• Therapeutic implications: Understanding the specific roles of SNF2H/SWI2 proteins in cancer provides opportunities for targeted interventions, including:

  • Development of small molecule inhibitors targeting specific chromatin remodeling activities

  • Synthetic lethal approaches exploiting dependencies created by mutations in these pathways

  • Biomarker development for patient stratification

What recent technical advances have improved the study of SNF2H/SWI2 chromatin remodeling mechanisms?

Recent technical advances have significantly enhanced our ability to study SNF2H/SWI2 chromatin remodeling mechanisms:

• Cryo-electron microscopy (cryo-EM): High-resolution structural studies of chromatin remodeling complexes have revealed:

  • Conformational changes during the ATP hydrolysis cycle

  • Interaction interfaces between remodelers and nucleosomes

  • Mechanistic insights into how ATP hydrolysis is coupled to mechanical work

• Single-molecule techniques:

  • FRET-based approaches allow real-time observation of nucleosome remodeling

  • Optical and magnetic tweezers provide direct measurement of forces generated during remodeling

  • These techniques have revealed the step size and directionality of remodeling events

• Genomic approaches:

  • CUT&RUN and CUT&Tag provide higher resolution mapping of chromatin remodeler binding sites

  • ATAC-seq allows genome-wide assessment of chromatin accessibility changes upon remodeler perturbation

  • Hi-C and micro-C reveal higher-order chromatin organization influenced by remodeling activities

• CRISPR-based tools:

  • Precise genome editing enables structure-function studies of endogenous remodelers

  • CRISPRi/CRISPRa systems allow temporal control of remodeler expression

  • CRISPR screens identify synthetic lethal interactions with remodeler mutations

• Improved biochemical purification:

  • Tandem affinity purification (TAP) strategies have enabled isolation of intact remodeling complexes with preserved activity

  • Recombinant expression systems allow production of defined complex compositions

  • Site-specific incorporation of photo-crosslinkable amino acids helps capture transient interactions

These technological advances collectively provide unprecedented insights into how SNF2H/SWI2 proteins harness the energy of ATP hydrolysis to remodel chromatin structure and regulate DNA-dependent processes.